Langhao Medical Technology (Hunan) Co., Ltd. announced that it has signed an agreement and issued common shares for a total gross proceeds of CNY 4 million in September, 2022. The transaction included participation from new investor, Tibet Duo Rui Pharmaceutical Co.,Ltd. for 25% stake. Out of CNY 4 million, CNY 3.3333 million is in registered capital and the rest in capital reserve.